Effects of tranexamic acid in amount of bleeding in patients with pelvic trauma
Phase 2
Recruiting
- Conditions
- Anticoagulant drugs.Anticoagulant antagonists, vitamin K and other coagulants
- Registration Number
- IRCT20130710013947N7
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 106
Inclusion Criteria
Patients with age 18-60 years oldAll the patients with pelvic trauma who admitted in hospital in first 3 hours after accident
Exclusion Criteria
Patients who died during the operation or studymultitraumaAnticoagulant drugs use such as A.S.A and dipyridamole; Increased in PT, PTT, INR;History of CVA, MI, bleeding disorder, TBI, CPR, Renal Failure, OCP;Pregnancy and breastfeedingPatients received pack
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood loss. Timepoint: 24hT 48h and 72 h. Method of measurement: based on blood pressure, Hb, Hct, Pulse rate.
- Secondary Outcome Measures
Name Time Method